[TREATMENT OF MANIC PATIENTS WITH CHLORPROTHIXENE (TRUXAL) IN COMPARISON WITH OTHER TREATMENT METHODS, WITH SPECIAL REFERENCE TO THE DURATION OF STABILIZATION].
D000654:Amobarbital; D014150:Antipsychotic Agents; D001714:Bipolar Disorder; D002746:Chlorpromazine; D002749:Chlorprothixene; D003295:Convulsive Therapy; D004565:Electroconvulsive Therapy; D005853:Geriatrics; D006801:Humans; D007328:Insulin; D008094:Lithium; D010546:Perphenazine; D011618:Psychotic Disorders
D014150:Antipsychotic Agents; D007328:Insulin; D008094:Lithium; D002749:Chlorprothixene; D010546:Perphenazine; D000654:Amobarbital; D002746:Chlorpromazine
AMOBARBITAL; CHLORPROMAZINE; CHLORPROTHIXENE; GERIATRICS; LITHIUM; PERPHENAZINE; PSYCHOSES, MANIC-DEPRESSIVE; SHOCK THERAPY, ELECTRIC; SHOCK THERAPY, INSULIN
BEHANDLUNG MANISCHER PATIENTEN MIT CHLORPROTHIXEN (TRUXAL) IM VERGLEICH MIT ANDEREN BEHANDLUNGSMETHODEN, BESONDERS MIT HINBLICK AUF DIE DAUER DER ZEIT DER STATIONIERUNG.